Data temporarily unavailable
Unable to load analysis for « - » for now. Try again in a few moments.

Investlytic score: 1/5 criteria met. Data as of 01/11/2026.
- ❌ Price trend failed
- ⚠️ Mixed growth
- ❌ Debt failed
- ✅ P/E passed
- ❌ Correction failed
Price trend
Overall trend (8 years): insufficient progression (less than x1.5).
Price change 2018 → 2019: 28.31%
Price change 2019 → 2020: -6.67%
Price change 2020 → 2021: -1.95%
Price change 2021 → 2022: -21.34%
Price change 2022 → 2023: 2.88%
Price change 2023 → 2024: 3.19%
Price change 2024 → 2025: 6.75%
Price change 2025 → 2026: 5.96%
Price change 2026 (year to date): 6.89%
Financial growth
Revenue CAGR (8 years): 2.52%
Earnings CAGR (8 years): 0.51%
Growth status: positive trend (>1%/yr) in revenue OR earnings, but not both.
Debt
Debt-to-equity ratio: 0.57
Debt/equity > 0.5 (maximum threshold).
P/E (Price/Earnings)
P/E ratio: 18.35
P/E < 25.0 (maximum threshold).
Correction (6 months)
Current correction: 0.00% from the high over 6 months.
Insufficient correction (< 10.0%).
Criteria of the Investlytic model
- / 5Free with the Investlytic logo. Paste this line into your page: options.
<script src="https://investlytic.co/encart.js" data-symbole="2M6.DE" data-lang="en"></script>Price trend
Price & trend
Interactive chart →💰 Dividend
Dividend ranking →⚖️ Comparison with the market
All stocks →| Stock | P/E | Dette/FP | Revenue growth | Rating |
|---|
Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.
Detailed analysis · Price trend
-
Revenues & profits
Revenue and net income
Financial indicators
Annual financial statements
| Fiscal year | Revenue | Net income | Net margin | EPS | Revenue growth |
|---|
Key reported figures
Revenue, net income and net margin reported by Medtronic Plc over the latest fiscal years.
| Fiscal year | Revenue | Net income | Net margin | Revenue growth |
|---|---|---|---|---|
| 2021 | 30.1 bn | 3.6 bn | 12.0 % | n/a |
| 2022 | 31.7 bn | 5.0 bn | 15.9 % | +5.2 % |
| 2023 | 31.2 bn | 3.8 bn | 12.0 % | -1.4 % |
| 2024 | 32.4 bn | 3.7 bn | 11.4 % | +3.6 % |
| 2025 | 33.5 bn | 4.7 bn | 13.9 % | +3.6 % |
| 2026 | 36.4 bn | 4.8 bn | 13.2 % | +8.4 % |
Amounts converted to USD. Source: published annual accounts, collected on 19/11/2026.
Valuation and competitors
Medtronic Plc compared with its sector on the same exchange and with its main competitors.
Trailing 12-month P/E. Sector: median of companies in the same sector listed on the same exchange, collected on 16/11/2026. Competitors: comparable companies named by the data provider.
Analyst consensus and forecasts
What the financial analysts covering Medtronic Plc publish: ratings, price targets and earnings forecasts.
Breakdown of ratings
Price targets: published for companies listed in the United States only.
Analyst forecasts
| Fiscal year | Revenue | Net income | Expected EPS (range) | P/E on this EPS | Analysts |
|---|---|---|---|---|---|
| 2026 | 36.1 bn | 7.2 bn | 5.52 (5.49 / 5.62) | n/a | 18 |
| 2027 | 39.0 bn | 7.7 bn | 5.98 (5.96 / 6.00) | n/a | 18 |
| 2028 | 40.3 bn | 8.2 bn | 6.39 (6.28 / 6.55) | n/a | 17 |
Amounts in USD, the reporting currency.
Track record against expectations: reported EPS above consensus 12 times over the last 12 releases.
Rating changes (12 months)
| Date | Firm | Before | After |
|---|---|---|---|
| 12/10/2026 | BTIG | Buy | Buy |
| 30/09/2026 | TD Cowen | Buy | Buy |
| 03/09/2026 | UBS | Buy | Buy |
| 02/09/2026 | RBC Capital | Outperform | Outperform |
| 02/09/2026 | Wells Fargo | Overweight | Overweight |
Source: ratings and forecasts published by analysts, collected on 14/11/2026. An analyst rating or target is not a guarantee. Company data collected from its MDT listing (same ISIN).
Dividends and earnings
Medtronic Plc: dividend history, last distributions, stock splits and earnings releases.
Annual dividend per share (), adjusted for splits. Light bar: current year, incomplete. Red bar: lower than the previous year.
Latest ex-dividend dates
| Ex-dividend | Amount | Payment |
|---|---|---|
| 25/09/2026 | 0.633 | 16/10/2026 |
| 26/06/2026 | 0.632 | 17/07/2026 |
| 27/03/2026 | 0.625 | 17/04/2026 |
| 29/12/2025 | 0.606 | 16/01/2026 |
| 26/09/2025 | 0.606 | 17/10/2025 |
| 27/06/2025 | 0.606 | 11/07/2025 |
| 28/03/2025 | 0.598 | 11/04/2025 |
| 27/12/2024 | 0.672 | 10/01/2025 |
Earnings releases
Next release: 24/11/2026. Expected EPS: 1.20.
| Date | Published EPS | Expected EPS | Surprise |
|---|---|---|---|
| 01/09/2026 | 1.26 | 1.21 | +4.1 % |
| 03/06/2026 | 1.32 | 1.31 | +0.8 % |
| 17/02/2026 | 1.15 | 1.13 | +1.8 % |
| 18/11/2025 | 1.18 | 1.14 | +3.5 % |
| 19/08/2025 | 1.10 | 1.08 | +1.9 % |
| 21/05/2025 | 1.43 | 1.40 | +2.1 % |
Factual data: ex-dividend history and earnings calendar, as of 18/11/2026. A past dividend does not guarantee the next one.
PEA and practical information
Rule applied: the French PEA accepts shares of companies headquartered in the European Union or the European Economic Area and subject to corporate income tax; ADRs and tax-exempt property companies (SIIC) are excluded. The institution holding the PEA confirms eligibility.
Frequently asked questions about Medtronic Plc
What is the revenue of Medtronic Plc?
36.4 bn USD for fiscal year 2026, with net income of 4.8 bn USD (net margin 13.2 %).
Does Medtronic Plc pay a dividend?
Yes. Latest dividend: 0.633 per share, ex-dividend on 25/09/2026. Over 12 months: 2.50.
When does Medtronic Plc report its next earnings?
The next release is expected on 24/11/2026. EPS expected by analysts: 1.33.
What do analysts say about Medtronic Plc?
Out of 51 analysts: 31 buy or strong buy, 20 hold, 0 sell or strong sell.
What is the P/E ratio of Medtronic Plc?
Trailing 12-month P/E of 18.6, against 32.5 for the sector median on the same exchange (10-year median: 26.9).
Is Medtronic Plc stock eligible for the French PEA?
Likely: the company is headquartered in the European Union or the European Economic Area (ISIN IE00BTN1Y115) and the stock is listed on a European exchange. The institution holding the PEA confirms eligibility.
How many employees does Medtronic Plc have?
95,000 full-time employees according to the latest published profile.
Who runs Medtronic Plc?
Geoffrey Straub Martha is the company's chief executive.